Monitoring and management of right ventricular function following cardiac transplantation

Transplantationsmedizin: Organ der Deutschen Transplantationsgesellschaft

Volumn 23, Issue 3, 2011, Pages 169-176

  Wagner, Frank ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Donor heart; Heart transplantation; Right ventricular function

Indexed keywords

EID: 84856782805     PISSN: 09469648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Stobierska-Dzierzek B, Awad H, Michler E (2001) The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 38: 923-931
2. Voelkel NF, Quaife RA, Leinwand LA et al. (2006) Right ventricular function and failure: Report of national heart, lung, and blood institute working group on cellular and molecular mechanisms of right heart failure. Circulation 114: 1883-1891
3. Leopore JJ, Bloch KD (2000) Nitric oxide and pulmonary hypertension. In: Loscalzo J,Vita JA (Eds.) Nitric oxide and the cardiovascular system (pp. 247-271).Totowa: Humana Press
4. Moraes DL, Colucci WS, Givertz MM (2000) Secondary hypertension in chronic heart failure: the role of the endothelium in pathophysiology and management. Circulation 102: 1718-1723
5. Barnard D, Alpert JS (1987) Right ventricular function in health and disease. J Clin Invest 12: 417-449
6. Abel FL, Waldhausen JA (1967) Effects of alterations in pulmonary vascular resistance on right ventricular function. J Thorac Cardiovasc Surg 54: 886-894
7. Mercat A, Diehl JL, Meyer G, Teboul JL, Sors H (1999) Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 27: 540-544
8. Jardin F, Genevray B, Brun-Ney D, Margairaz A (1985) Dobutamin: a hemodynamic evaluation in pulmonary embolism shock. Crit Care Med 13: 1009-1012
9. Vincent JL, Reuse C, Kahn RJ (1988) Effects on right ventricular function of a change from dopamine to dobutamine in critically ill patients. Crit Care Med 16: 659-662
10. Boulain T, Lanotte R, Legras A, Perrotin D (1993) Efficacy of epinephrine therapy in shock complicating pulmonary embolism. Chest 104: 300-302
11. Colluci WS (1991) Cardiovascular effects of milrinone. Am Heart J 121:1945-1947
12. Chen EP, Bittner HB, Davis RD, van Trigt P (1998) Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. J Heart Lung Transplant 17: 669-678
13. Toller WG, Stranz C (2006) Levosimendan, a new inotropic and vasodilator agent. Anesthesiology 104: 556-569
14. Packer M, Greenberg B, Massie B, Dash H (1982) Deleterious effects of hydralazine in patients with pulmonary hypertension New Engl J Med 306: 1326-1331
15. Rajek A, Pernerstorfer T, Kastner J, Mares P, Grabenwoger M, Sessler DI, Grubhofer G, Hiesmayr M (2000) Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E(1) during heart transplantation. Anesth Analg 90: 523-530
16. Fullerton DA, Jones SD, Grover FL, McIntyre RC (1996) Adenosine effectively controls pulmonary hypertension after cardiac operations. Ann Thorac Surg 61: 1118-1124
17. Bush A, Busst CM, Clarke B, Barnes PJ (1989) Effect of infused adenosine on cardiac output and systemic resistance in normal subjects. Br J Clin Phamacol 27: 165-171
18. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. New Engl J Med 329: 2002-2012
19. Rimar S, Gillis CN (1993) Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 88: 2884-2887
20. Roissant R, Falke KJ, Lopez F, Slama K, Pison U, Zapol WM (1993) Inhaled nitric oxide for the adult respiratory distress syndrome. New Engl J Med 328: 399-405
21. Nishimura M, Hess D, Kacmarek RM, Ritz B, Hurford WE (1995) Nitrogen dioxide production during mechanical ventilation with nitric oxide in adults. Effects of ventilator internal volume, air versus nitrogen dilution, minute ventilation, and inspired oxygen fraction. Anesthesiology 82: 1246-1254
22. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis K, Hyers TM, Papadakos P (1998) Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 26: 15-23
23. Lavoie A, Hall JB,Olson DM,Wylam ME (1996) Lifethreatening effects of discontinuing inhaled nitric oxide in severe respiratory failure. Am J Resp Crit Care Med 153: 1985-1987
24. Cuthbertson BH, Dellinger P, Dyar OJ, Evans TE, Higgenbottam T, Latimer R, Payen D, Stott SA, Webster NR, Young JD (1997) UK guidelines for the use of inhaled nitric oxide therapy in adult ICU's. American-European Consensus Conference on ALI/ARDS. Intensive Care Med 23: 1212-1218
25. Roberts JD, Fineman JR, Morin FC, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, Zapol WM (1997) Inhaled nitric oxide and persistant pulmonary hypertension of the newborn.The inhaled nitric oxide study group. New Engl J Med 336: 605-610
26. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS (1994) Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation 90: 2780-2785
27. Carrier M, Blaise G, Belisle S,Perfault LP,Pellerin M, Petitclerc R,Pelletier LC (1999) Nitric oxide inhalation in the treatment of primary graft failure following heart transplantation. J Heart Lung Transplant 18: 664-667
28. Ardehali A, Hughes K, Sadeghi A, Esmailian F, Marelli D, Moriguchi J, Hamilton MA, Kobashigawa J, Laks H (2001) Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation 72: 638-641
29. Auler JO Jr,Carmona MJ, Bocchi EA, Bacal F, Fiorelli AI, Stolf NA, Jatene AD (1996) Low doses of inhaled nitric oxide in heart transplant recipients. J Heart Lung Transplant 15: 443-450
30. Boffini M, Sansone F, Ceresa F et al. (2009) Role of oral sildenafil in the treatment of right ventricular dysfunction after heart transplantation. Transplant Proc 41: 1353-1356
31. Michelakis E, Tymchak W, Lien D et al. (2002) Oral sildenfil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide. Circulation 105: 2398-2403
32. Lang JD, Lell W (2001) Pro: Inhaled nitric oxide should be used routinely in patients undergoing lung transplantation. J Cardiothorac Vasc Anaesth 15: 785-789
33. Haraldsson A, Kieler-Jensen N, Nathorst-Westfeld U, Bergh CH,Ricksten SE (1998) Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest 114: 780-786
34. Hoeper MM, Schwarze M, Ehlerding S, Adler-Schuermeyer A, Spickerkötter E, Niedermeyer J, Hamm M, Fabel H (2000) Long-term treatment of primary pulmonary hypertension with aerolized iloprost, a prostaglandin analogue. New Engl J Med 342: 1866-1870
35. Stewart DJ, Levy RD, Cernacek P, Langleben D (1991) Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Internal Med 114: 464-469
36. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S,Masaki T, Duguid WP, Stewart DJ (1993) Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med 328: 1732-1739
37. Dupuis J, Stewart DJ, Cernacek P, Gosselin G (1996) Human pulmonary circulation is an important site for both clearance and production of endothelin-1. Circulation 94: 1578-1584
38. Channick RN, Simonneau G, Sitbon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainision M, Bodin F, Rubin LJ (2001) Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 358: 1119-1123
39. Roberts DH, Lepore JJ, Maroo A, Semigran MJ, Ginns LC (2001) Oxygen therapy improves cardiac index and pulmonary vascular resistance in patients with pulmonary hypertension. Chest 120: 1547-1555
40. Darrah WC, Sharpe MD, Guiraudon GM, Neal A (1997) Intraaortic balloon counterpulsation improves right ventricular failure resulting from pressure overload. Ann Thor Surg 64: 1718-1723
41. Emery RW, Frazier E, Joyce LD, Von Rueden TJ, King MR, Jorgensen CR, Pritzker MR, Johnson KE, Lake KD, Arom KV (1991) Mechanical circulatory assistance after heart transplantation. Ann Thorac Surg 51: 43-47
42. Rich S, Gubin S, Hart K (1990) The effects of phenylephrine on right ventricular performance in patients with pulmonary hypertension. Chest 98: 1102-1106
43. Ducas J, Duval D, Dasilva H, Boiteau P, Prewitt RM (1987) Treatment of a canine pulmonary hypertension: effects of norepinephrine and isoproterenol on pulmonary vascular pressure-flow characteristics. Circulation 75: 235-242
44. Emery RW, Eales F, Joyce LD, Von Rueden TJ, King RM, Jorgensen CR, Pritzkar MR, Johnson KE, Laka KD, Arom KV (1991) Mechanical circulatory assistance after heart transplantation. Ann Thorac Surg 51: 43-47
45. Chen JM, Levin HR, Rose EA Addonizio LJ, Landry DW, Sistina JJ, Michler RE, Oz MC (1996) Experience with right venticular assist devices for perioperative right-sided circulatory failure. Ann Thor Surg 61: 305-310